Blue Automobiles to Lift COVID Blues? PPG 2020 Automotive Color Report Shows Blue Hues Maintaining Pre-Pandemic Growth
9.2.2021 18:04:00 EET | Business Wire | Press release
PPG (NYSE:PPG) today released its 2020 automotive color popularity report, which shows blue hues continuing to increase in popularity. The optimistic color climbed to 9% of global color share – a 1% increase from 2019.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210209005301/en/
PPG released its 2020 automotive color popularity report, showing blue hues continuing to increase in popularity. The optimistic color climbed to 9% of global color share – an increase from 2019. (Graphic: Business Wire)
The trend reinforces PPG’s 2019 automotive color forecast, which anticipated that sales of blue automobiles would increase over the next four years. PPG experts believe the global COVID-19 pandemic is likely to further fuel global preference for the color.
“COVID-19 has consumers focusing on their desires and priorities,” said Misty Yeomans, PPG color styling manager, Americas. “Blue is an optimistic, comforting color that conveys trust, dependability, confidence, healing and hope. It’s also associated with nature, cleanliness and future-forward technology.”
While blue held steady in most regions, it increased 1% in Asia-Pacific markets, accounting for virtually all the color’s overall global growth. In North America, blues held at 10% of the color share, but became more popular on minivans, compact cars and sports cars. Blue now commands 15% of the sports car segment in the region.
In Europe, blue occupies 11% of the market. Sales of blue luxury, mid-size and sub-compact vehicles grew by 1% across the continent last year. In China, the purchase of blue sub-compacts jumped by 4% and blue mid-size cars by 2%, but the color fell by 6% in minivans.
As the movement toward blue continues, Yeomans expects the color to emerge in more vivid or desaturated shades, deep-sea luxury tones and hues with a slight turquoise influence.
“Digital-inspired aqua-blues combine versatility with a sense of youthfulness and a fresh spirit,” said Yeomans. “The emergence of the electric vehicle (EV) market also will drive growth in vibrant tones and interesting effects, such as color-shifting colors. We’re also seeing blue used more extensively in trim lines, logos and other accessorizing applications.”
Consumer demand and the need to accommodate autonomous driving technologies helped white remain the world’s most popular automobile color. While preference for white tones fell 1% from 2019, solid and metallic shades of the color claimed 34% of the cars purchased worldwide in 2020, according to PPG’s report. This was led by 41% of auto builds in the Asia-Pacific region, which is a boost of 1% from 2019, and 36.5% in South America, where demand fell by 2.5%. In North America, white metallics leapt substantially in the luxury car segment, from 21% last year to 38% in 2020.
“White colors also reflect consumers’ desire for refined simplicity and versatility in turbulent times,” Yeomans said. “In addition to the pearl and metallic whites that are already widely popular, we anticipate a new dimension of white stylings in the automotive market that create a warm, sophisticated feel, such as creamy shades of ivory or bone-colored tints and ceramic effects. White colors are also highly compatible with emerging radar and LiDAR technologies that enable self-driving vehicles.”
Together, green, blue and natural shades accounted for 16% of the global automotive color share. This figure is consistent across all regions except South America, where white, silver, black and gray virtually eliminate these hues.
“Red is consistent and an important color space in the automotive market, holding steady at 8% globally,” said Yeomans. “This color will get a new push with EV start-ups due to its stand-out nature and association with sports car models. Year after year, we see high chromatic reds growing in interest.”
Holding steady at 18% compared to 2019, black retained its popularity as a core color due to its versatility and dramatic design potential.
“Effects and finishes that incorporate black tones allow for artistic reveals in the way color shifts, highlighting hidden undertones and adding a dramatic flair to the possibilities provided by the new pigments and finishes being developed within this color family,” Yeomans said.
Globally, a slight decrease in the popularity of silver was balanced by a corresponding increase in preferences for gray. Silver tones dropped from 15% of auto builds in 2019 to 12% in 2020. Grays rose from 10% to 12% during the same period.
PPG forecasts that gray will remain a popular core color for automotive stylists moving forward, driven by the resurgence of concrete and stone materials and the ongoing appeal of ceramic and metal tones. The gray palette will shift toward warmer hues with brown influences, while blue-inflected grays will retain their fashionability.
The influence from nature will be apparent in silver stylings moving forward as well, according to PPG experts. Warmer and more organic tones will further reflect current consumer tastes, while also aligning with the highly compatible nature of very light tones, including whites, with new radar and LiDAR technologies.
Because PPG coats more surfaces than any other company and its paint colors are sold in more than 70 countries, developing color trends is a global, cross-cultural effort. Fact-based collaboration among more than 20 PPG color experts generates the company’s color trends and consumer preferences, resulting in a unified voice on color direction.
PPG color stylists around the world specialize in industries that include consumer electronics, architectural, automotive and aerospace. These experts study consumer mindsets, building material trends, wellness preferences and more to select a curated color forecast that resonates and is reflective of current consumer attitudes and spans cultures, regions and markets.
EDITOR’S NOTE: For more information on PPG’s automotive color popularity report, visit news.ppg.com/2020automotivecolor. For more information on PPG’s architectural coatings color trends, visit news.ppg.com/2021colortrends.
PPG: WE PROTECT AND BEAUTIFY THE WORLD™
At PPG (NYSE:PPG), we work every day to develop and deliver the paints, coatings and materials that our customers have trusted for more than 135 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 70 countries and reported net sales of $13.8 billion in 2020. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com.
We protect and beautify the world is a trademark and the PPG Logo is a registered trademark of PPG Industries Ohio, Inc.
CATEGORY Automotive OEM Coatings
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005301/en/
Contact information
PPG Media Contacts:
Keith Rigby
Automotive OEM Coatings
+1 724-678-1453
krigby@ppg.com
Greta Edgar
Corporate Communications
+1 724-316-7552
edgar@ppg.com
www.ppg.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained Improvement in TGCT Symptoms and Joint Function26.10.2026 13:00:00 EET | Press release
Merck, a leading science and technology company, today announced new two-year follow-up results from the Phase 3 MANEUVER study evaluating pimicotinib in patients with tenosynovial giant cell tumor (TGCT). The study showed that among patients initially randomized to pimicotinib, improvements in symptoms and joint function were observed as early as Week 5, sustained through two years, and continued to improve over time. Tumor responses remained robust1 and durable,2 and the safety profile was consistent with previous analyses. The findings are being presented today in the Sarcoma poster session at the European Society for Medical Oncology (ESMO) Congress 2026 (Presentation # 3747P). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022786567/en/ David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck "For people living with TGCT, the impact of the disease is often felt through persis
WHOOP and Samuel Ross MBE Unveil Layer 2 of PROJECT TERRAIN26.10.2026 12:30:00 EET | Press release
WHOOP, the human performance brand, today announced Layer 2 of PROJECT TERRAIN, its multiyear collaboration with British designer Samuel Ross MBE and his design atelier, SR_A. Building on the sold out debut collection launched in March 2026, Layer 2 expands PROJECT TERRAIN to its next season connecting lifestyle and performance for movement, adaptability and zone based training. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026029587/en/ WHOOP and Samuel Ross MBE Unveil Layer 2 of PROJECT TERRAIN While the first PROJECT TERRAIN collection harnessed dense cities and modern training grounds, Layer 2 explores performance through material, silhouette and tactility. Drawing on the textures, conditions, and flux of the natural world, the collection introduces a newly developed system of WHOOP bands, Italian technical apparel, outerwear, and accessories designed to move between urban and outdoor settings. Performance extends be
Bleeding gums? Don't ignore the warning signs – the first stage of gum disease can be reversed26.10.2026 12:28:00 EET | Press release
Gums bleeding when brushing can happen to any of us, and it is easy to ignore. But blood in the sink is a sign that something is not right with your mouth. Bleeding gums often indicate gingivitis, the earliest and most common form of gum disease. The good news: gingivitis can be reversed with proper oral hygiene. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022835650/en/ Oral-B iO Left untreated, gingivitis can progress into periodontitis, a more severe stage of gum disease that can only be managed, not reversed, and can lead to losing teeth over time. Healthy gums matter beyond the mouth, too. Oral health and systemic health are deeply interconnected, with inflammation and bacteria from oral diseases contributing to conditions such as heart disease, diabetes and dementia. "Gums bleeding when brushing can happen to any of us. When they do, it shouldn't be ignored," said Eva Castro Perea, who holds a degree in dentistry
Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 202626.10.2026 09:00:00 EET | Press release
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced the presentation of new clinical and translational research in peripheral neuropathic pain (PNP) at the International Association for the Study of Pain (IASP) 2026 World Congress in Bangkok, Thailand, taking place from 26 to 30 October. The research spans new Phase 2 findings on incobotulinumtoxinA in postherpetic neuralgia (PHN) and post-surgical/post-traumatic neuropathic pain (PS/PTNP), as well as preclinical studies exploring potential biological mechanisms involved in effects of incobotulinumtoxinA on PNP models, highlighting Merz Therapeutics’ growing presence in neuropathic pain. In the PHN population of the Phase 2 PaiNT trial, results over 20 weeks favored incobotulinumtoxinA versus placebo treatment. In an exploratory analysis of average daily pain (ADP) intensity, the greatest difference between treatment groups was observed at Week 6 (adjusted mean difference, −1.14 points; p=0.0488).
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
